⌘K

Login Start Free

PROGENICS PHARMACEUTICALS INC·4

May 16, 2:23 PM ET

PROGENICS PHARMACEUTICALS INC 4

4 · PROGENICS PHARMACEUTICALS INC · Filed May 16, 2008

Insider Transaction Report

Form 4

Period: 2008-05-14

PROGENICS PHARMACEUTICALS INCPGNX

Director

Transactions

Exercise/Conversion
Common Stock
2008-05-14$4.41/sh+2,500$11,025→ 73,500 total
Exercise/Conversion
Common Stock
2008-05-14$6.66/sh+2,500$16,650→ 76,000 total
Exercise/Conversion
Common Stock
2008-05-14$5.02/sh+2,500$12,550→ 78,500 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2008-05-14−2,500→ 0 total
Exercise: $4.41From: 2003-04-01Exp: 2013-05-31→ Common Stock (2,500 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2008-05-14−2,500→ 0 total
Exercise: $5.02From: 2002-10-01Exp: 2012-10-01→ Common Stock (2,500 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2008-05-14−2,500→ 0 total
Exercise: $6.66From: 2003-01-01Exp: 2014-01-01→ Common Stock (2,500 underlying)

Holdings

Common Stock
(indirect: By Partnership)
16,500

Signature

Mark F. Dalton|2008-05-16

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT